Luís Almeida - Concepedia

Author

Luís Almeida

Also Known As

Almeida, Luís, L Almeida, L. Almeida, L. H. S. Almeida, Larissa F.L. Almeida, Laura Ferreira de Almeida, Laís Bastos de Almeida, Levy Enéas Da Silva Almeida, Luis Almeida, Luis Gustavo Nunes de Almeida

146

Publications

4.4K

Citations

H-Index

110

Concepts

All Affiliations

Bial (Portugal)Universidade do Porto University of Aveiro University of Coimbra University of Bonn

About

Luís Almeida is an author at Bial (Portugal) specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	37	1.6K
2	Social Sciences	5	5	204
3	Engineering	1	1	25
4	Public Health	1	1	82
5	Behavioral Health	1	1	44

Luís Almeida

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
Pharmacokinetic and safety profile of<i>trans</i>‐resveratrol in a rising multiple‐dose study in healthy volunteers Luís Almeida, Manuel Vaz‐da‐Silva, Amílcar Falcão, Molecular Nutrition & Food Research	2009	421
Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial‐onset seizures: A randomized, double‐blind, placebo‐controlled, parallel‐group phase III study Christian E. Elger, Péter Halász, Joana Maia, Epilepsia	2009	247
Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy Elinor Ben‐Menachem, Alberto Alain Gabbai, A. Hufnagel, Epilepsy Research Adjunctive TherapyPsychiatryPartial EpilepsyPsychotropic MedicationEslicarbazepine Acetate	2010	179
Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures António Gil‐Nagel, J. Lopes-Lima, Luís Almeida, Acta Neurologica Scandinavica	2009	159
Eslicarbazepine Acetate: A Double‐blind, Add‐on, Placebo‐controlled Exploratory Trial in Adult Patients with Partial‐onset Seizures Christian E. Elger, Meir Bialer, Joyce A. Cramer, Epilepsia	2007	130
Pharmacokinetics of <i>Trans</i>‐resveratrol Following Repeated Administration in Healthy Elderly and Young Subjects Teresa Nunes, Luís Almeida, José‐Francisco Rocha, The Journal of Clinical Pharmacology AgingGeriatricsYoung SubjectsPharmacologyPhysical Aging	2009	108
Effect of food on the pharmacokinetic profile of trans-resveratrol Manuel Vaz‐da‐Silva, Ana I. Loureiro, Amílcar Falcão, International Journal of Clinical Pharmacology and Therapeutics	2008	101
Single‐Dose and Steady‐State Pharmacokinetics of Eslicarbazepine Acetate (BIA 2–093) in Healthy Elderly and Young Subjects Luís Almeida, Amílcar Falcão, Joana Maia, The Journal of Clinical Pharmacology Therapeutic Drug MonitoringGeriatricsSteady‐state PharmacokineticsPharmacoepidemiologyPharmacology	2005	101
Long‐term efficacy and safety of eslicarbazepine acetate: Results of a 1‐year open‐label extension study in partial‐onset seizures in adults with epilepsy Péter Halász, Joyce A. Cramer, Danilo Hodoba, Epilepsia	2010	96
Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment Luís Almeida, Johané Potgieter, Joana Maia, European Journal of Clinical Pharmacology HepatologyLiver PhysiologyPharmacologyEslicarbazepine AcetateHepatotoxicity	2007	96

Page 1